Compare RPRX to:
After Hours:
0.7161
0.01 (1.79%) 4:09pm ET
| Last Trade: | 0.7035 |
|---|---|
| Trade Time: | 4:00pm ET |
| Change: | |
| Prev Close: | 0.72 |
| Open: | 0.73 |
| Bid: | 0.70 x 2000 |
| Ask: | 0.735 x 6900 |
| 1y Target Est: | 5.25 |
| Day's Range: | 0.70 - 0.73 |
|---|---|
| 52wk Range: | 0.65 - 13.94 |
| Volume: | 303,672 |
| Avg Vol (3m): | 1,889,020 |
| Market Cap: | 17.97M |
| P/E (ttm): | N/A |
| EPS (ttm): | -2.081 |
| Div & Yield: | N/A (N/A) |
| Thu, Nov 19 | REPROS THERAPEUTICS INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, FinanciEDGAR Online |
| Tue, Nov 17 | REPROS THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhiEDGAR Online |
| Tue, Nov 17 | Genzyme's Termeer: Worst Biotech CEO of '09at TheStreet.com |
| Mon, Nov 16 | [video] Collagen Disease Breakthroughat TheStreet.com |
| Fri, Nov 13 | REPROS THERAPEUTICS INC. FinancialsEDGAR Online Financials |
| Thu, Nov 12 | Repros Appoints Dr. Jaye Thompson to Board of DirectorsBusiness Wire |
| Tue, Nov 10 | REPROS THERAPEUTICS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or StEDGAR Online |
| Mon, Nov 9 | Repros to Appeal NASDAQ Delisting NoticeBusiness Wire |
| Mon, Nov 9 | REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andEDGAR Online |
| Mon, Nov 9 | REPROS THERAPEUTICS INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.